Literature DB >> 9864029

HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients.

O Molberg1, K E Lundin, E M Nilsen, H Scott, K Kett, P Brandtzaeg, E Thorsby, L M Sollid.   

Abstract

Celiac disease is a common HLA-DQ2-associated enteropathy caused by an abnormal T-cell-mediated immune response to ingested wheat gliadin proteins. We have previously isolated in situ activated mucosal T cells from celiac disease patients and demonstrated that these T cells were gliadin specific and predominantly DQ2 restricted. In contrast to this, gliadin-specific T cells isolated from peripheral blood display a variable HLA restriction pattern, thereby indicating that the skewed DQ restriction of T cells resident in the celiac lesions could be dictated by a preference for DQ-mediated antigen presentation in the mucosa of CD patients. To address this, we analyzed the HLA restriction of T cells recognizing astrovirus, a common gastroentetitis virus, isolated from intestinal mucosa of six celiac disease patients. As an internal control, gliadin-specific T cells were isolated and analyzed in parallel. The gliadin-specific mucosal T cells were marked in their DQ2 restriction, whereas the parallel astrovirus-specific T cells were predominantly restricted by DR molecules. Our data indicate that the repertoire of T cells present in celiac lesions is determined by the priming antigen(s) and not by a skewing in the expression of functional HLA class II isotypes in the disease affected small intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9864029     DOI: 10.1111/j.1399-0039.1998.tb03066.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

Review 1.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  T cells in peripheral blood after gluten challenge in coeliac disease.

Authors:  R P Anderson; D A van Heel; J A Tye-Din; M Barnardo; M Salio; D P Jewell; A V S Hill
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

3.  Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease.

Authors:  E H Arentz-Hansen; S N McAdam; O Molberg; C Kristiansen; L M Sollid
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

4.  Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.

Authors:  R P Anderson; G Goel; M Y Hardy; A K Russell; S Wang; E Szymczak; R Zhang; K E Goldstein; K Neff; K E Truitt; L J Williams; J L Dzuris; J A Tye-Din
Journal:  Clin Exp Immunol       Date:  2021-02-28       Impact factor: 5.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.